Vera Therapeutics Inc Cl A (VERA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -152,148 | -108,723 | -62,091 | -28,383 | -95,990 |
| Depreciation Amortization | -8,057 | -6,263 | -4,063 | -1,469 | -4,086 |
| Accounts payable and accrued liabilities | -3,453 | -6,516 | -6,454 | -5,909 | -873 |
| Other Working Capital | 2,660 | 3,388 | -2,475 | -8,619 | -5,822 |
| Other Operating Activity | 26,319 | 22,617 | 16,471 | 10,550 | 14,590 |
| Operating Cash Flow | $-134,679 | $-95,497 | $-58,612 | $-33,830 | $-92,181 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -972 | -327 | -89 | N/A | -63 |
| Purchase Of Investment | -703,015 | -409,000 | -336,055 | -254,967 | -224,930 |
| Sale Of Investment | 278,958 | 205,681 | 94,181 | 35,681 | 185,562 |
| Investing Cash Flow | $-425,029 | $-203,646 | $-241,963 | $-219,286 | $-39,431 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | N/A | N/A | 24,741 |
| Common Stock Issued | 645,913 | 298,602 | 297,850 | 294,411 | 116,056 |
| Common Stock Repurchased | -13 | -13 | N/A | N/A | N/A |
| Other Financing Activity | -39,227 | -17,871 | -17,871 | -17,871 | -7,256 |
| Financing Cash Flow | $606,673 | $280,718 | $279,979 | $276,540 | $133,541 |
| Beginning Cash Position | 45,681 | 45,681 | 45,681 | 45,681 | 43,752 |
| End Cash Position | 92,646 | 27,256 | 25,085 | 69,105 | 45,681 |
| Net Cash Flow | $46,965 | $-18,425 | $-20,596 | $23,424 | $1,929 |
| Free Cash Flow | |||||
| Operating Cash Flow | -134,679 | -95,497 | -58,612 | -33,830 | -92,181 |
| Capital Expenditure | -972 | -327 | -89 | N/A | -63 |
| Free Cash Flow | -135,651 | -95,824 | -58,701 | -33,830 | -92,244 |